Literature DB >> 21431448

[Indolent firm reddish papules. Cutaneous Rosai-Dorfman disease].

G Bens1, R Kerdraon, J-J De Kyvon, E Estève.   

Abstract

Sinus histiocytosis with massive lymphadenopathy (SHML) is generally characterized by severe illness and massive cervical lymphadenopathy. Sinus histiocytosis limited to the skin is now recognized as a rare distinct entity called cutaneous Rosai-Dorfman disease (CRD). We report CRD in a 57-year-old male patient presenting with disseminated firm red-brown papules. Histology revealed a dermal infiltrate with CD1a-, CD68+, S100+ multinuclear giant cells. Some of these histiocytes showed hemophagocytosis (emperipolesis). We achieved a good therapeutic result with topical clobetasol propionate.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21431448     DOI: 10.1007/s00105-011-2140-y

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  5 in total

1.  Rosai-Dorfman disease manifesting as multiple subcutaneous nodules. Report of a case with diagnosis on a fine needle aspirate.

Authors:  N Gopendro Singh; Kusum Kapila; Sandeep Mathur; Ruma Ray; Kusum Verma
Journal:  Acta Cytol       Date:  2004 Mar-Apr       Impact factor: 2.319

2.  Sinus histiocytosis (Rosai-Dorfman disease) clinically limited to the skin. An immunohistochemical and ultrastructural study.

Authors:  C Perrin; J F Michiels; J P Lacour; A Chagnon; J G Fuzibet
Journal:  J Cutan Pathol       Date:  1993-08       Impact factor: 1.587

3.  Cutaneous sinus histiocytosis (Rosai-Dorfman disease) presenting clinically as vasculitis.

Authors:  Catherine M Stefanato; Philip S Ellerin; Jag Bhawan
Journal:  J Am Acad Dermatol       Date:  2002-05       Impact factor: 11.527

4.  Clinical and histopathologic spectrum of cutaneous Rosai-Dorfman disease in Taiwan.

Authors:  Ching-I Lu; Tseng-tong Kuo; Wen-Ron Wong; Hong-Shang Hong
Journal:  J Am Acad Dermatol       Date:  2004-12       Impact factor: 11.527

5.  Cutaneous rosai-dorfman disease is a distinct clinical entity.

Authors:  Thomas Brenn; Eduardo Calonje; Scott R Granter; Niamh Leonard; Wayne Grayson; Christopher D M Fletcher; Phillip H McKee
Journal:  Am J Dermatopathol       Date:  2002-10       Impact factor: 1.533

  5 in total
  2 in total

1.  Combined treatment for cutaneous Rosai-Dorfman disease: a report of 2 cases.

Authors:  Jian-Xin Xia; Xian-Hua Jin; Yan Mou; Xue Li; Kai Yu; Wen-Jing Zhu; Fu-Qiu Li
Journal:  Int J Clin Exp Med       Date:  2013-09-25

2.  Purely cutaneous rosai-dorfman disease with immunohistochemistry.

Authors:  Uzma Farooq; Anna H Chacon; Vladimir Vincek; George W Elgart
Journal:  Indian J Dermatol       Date:  2013-11       Impact factor: 1.494

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.